• Users Online: 3065
  • Print this page
  • Email this page


 
 Table of Contents    
LETTERS TO EDITOR
Year : 2020  |  Volume : 64  |  Issue : 14  |  Page : 156-158  

Visualized effect of the Frankfurt COVid aErosol pRotEction Dome – COVERED


Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Frankfurt, Germany

Date of Submission12-May-2020
Date of Decision13-May-2020
Date of Acceptance13-May-2020
Date of Web Publication23-May-2020

Correspondence Address:
Dr. Florian J Raimann
Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Theodor-Stern Kai 7, 60590 Frankfurt
Germany
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ija.IJA_569_20

Rights and Permissions

How to cite this article:
Kloka JA, Martin C, Gilla P, Lotz G, Zacharowski K, Raimann FJ. Visualized effect of the Frankfurt COVid aErosol pRotEction Dome – COVERED. Indian J Anaesth 2020;64, Suppl S2:156-8

How to cite this URL:
Kloka JA, Martin C, Gilla P, Lotz G, Zacharowski K, Raimann FJ. Visualized effect of the Frankfurt COVid aErosol pRotEction Dome – COVERED. Indian J Anaesth [serial online] 2020 [cited 2020 Oct 22];64, Suppl S2:156-8. Available from: https://www.ijaweb.org/text.asp?2020/64/14/156/284921



Sir,

In the context of the current SARS-CoV-2 pandemic, the protection of medical staff taking care of COVID-19 patients is of great importance. The virus is mainly transmitted via droplet infection.[1] Therefore, measures that expose medical personnel to aerosol formation represent a high risk of infection. In the past, infections among medical personnel have occurred several times.[2] One of the dangerous measures is managing the airway by the medical staff during elective operations. Especially in emergency situations or in emergency rooms, where the infection status of the patient is unclear doctors and nursing staff are exposed to particularly high risk situations.[3] Recommendations for the protection of medical personnel are published worldwide adapted to the relevant local standards.[4],[5] Here, COVERED can offer a useful complementary solution.

The pandemic situation may result in a lack of personal protective equipment due to the high numbers of patients. Pragmatic solutions help to bridge the shortage of resources and still provide the highest possible level of protection for medical staff. The COVid aErosol pRotEction Dome - COVERED was developed in Frankfurt, Germany, for this purpose.

We wanted to build a device that should be easy to manufacture without high costs and what can be disinfected easily. Ideally, the raw material should have no other use and be available in sufficient numbers in the current situation. For this purpose, we cut the packaging tray used for heart-lung-machine sets into 2 parts and then reconnected them with standard plastic glue. The bond points were then sealed with silicone.

This device has been used at the Frankfurt University Hospital for droplet protection since the beginning of the SARS-CoV-2 pandemic. In the context of an evaluation of personal protection equipment, a mannequin (Laerdal Airway Management Trainer, Laerdal, Stavanger, Norway) was fitted with a mucosal atomization device (MAD) in the throat, connected to a perfusor line and a syringe. The system was filled with a fluorescent dye (Fluorescein, Wark24, Alsdorf, Germany). The used MAD produces a fine aerosol with a drop size of 30-100 microns.[6] This pragmatic approach seemed to us to be most suitable for the representation of aerosols produced during coughing. However, smaller or larger droplets can also occur in vivo. The aerosol formation is visible as a fine fog [Figure 1]b. The mannequin was then placed in the COVERED [Figure 1]a. The protective effect was evaluated by means of fluorescent residues on one employee. An excellent protective effect by COVERED was shown, as no fluorescent residues could be detected on the personal protective equipment of the airway manager [Figure 2]a.
Figure 1: Experimental set-up. Experimental set-up with COVERED to protect the employees (a). Generation of aerosol during coughing without COVERED (b)

Click here to view
Figure 2: Effect of DOME: Reduced contamination of anesthetist. The protective effect of COVERED against coughing during intubation is made visible with fluorescent dye. No residues on the face shield of the protected airway manager (a). Visible dye on the face shield of the unprotected airway manager (b and c)

Click here to view


In a second test round, the COVERED was removed and an intubation was performed with a face shield only. Here too, a cough of the patient was simulated with fluorescent dye. This resulted in a clear contamination of the test person. This contamination is shown in [Figure 2]b and [Figure 2]c.

After showing the picture to our medical stuff, COVERED is highly accepted and included in our daily routine. Therefore, we would like to share those pictures with the scientific community.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
The World Health Oranization Modes of transmission of virus causing COVID-19: Implications for IPC precaution recommendations. 2020.  Back to cited text no. 1
    
2.
COVID-19: Protecting health-care workers. Lancet 2020;395:922.  Back to cited text no. 2
    
3.
Orser BA. Recommendations for endotracheal intubation of COVID-19 patients. Anesth Analg 2020;130:1109-10.  Back to cited text no. 3
    
4.
Malhotra N, Bajwa SJS, Joshi M, Mehdiratta L, Trikha A. Indian society of anaesthesiologists (ISA National) advisory and position statement regarding COVID-19. Indian J Anaesth 2020;64:259-63.  Back to cited text no. 4
  [Full text]  
5.
Bajwa SJS, Sarna R, Bawa C Mehdiratta L. Peri-operative and critical care concerns in coronavirus pandemic. Indian J Anaesth, 2020;64:267-74.  Back to cited text no. 5
    
6.
Hosseini S, Wei X, Wilkins JV, Fergusson CP, Mohammadi R, Vorona G, et al. In vitro measurement of regional nasal drug delivery with flonase,((R)) Flonase((R)) sensimist, and MAD nasal in anatomically correct nasal airway replicas of pediatric and adult human subjects. J Aerosol Med Pulm Drug Deliv 2019;32:374-85.  Back to cited text no. 6
    


    Figures

  [Figure 1], [Figure 2]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References
    Article Figures

 Article Access Statistics
    Viewed542    
    Printed3    
    Emailed0    
    PDF Downloaded117    
    Comments [Add]    

Recommend this journal